Severe Altitude Illness: Drowsiness, Ataxia, and 68% Oxygen Saturation

⛰️ HIGH ALTITUDE CEREBRAL EDEMA (HACE)
Internal Medicine Quiz · Postgraduate MCQ Series

📋 History

🧑 Age / Sex: 29-year-old male, otherwise healthy

🏔️ Exposure: Rapid ascent to 4,200 m elevation (no acclimatization)

🤕 Symptom 1: Severe headache (onset after ascent)

🚶 Symptom 2: Difficulty walking (progressive)

😴 Symptom 3: Drowsiness and disorientation to time and place

🩺 Examination

🧠 Mental Status: Drowsy, disoriented to time and place

🚶 Gait: Wide-based (ataxic) gait

💉 Vitals: SpO₂ 68% on room air — severely hypoxic

Note: No signs of papilledema documented; focal neurological deficits absent in this case.

🔬 Investigation

• Pulse Oximetry: SpO₂ 68% (severe hypoxemia at altitude)
• ABG (if available): Respiratory alkalosis ± hypoxia
• MRI Brain: Increased T2/FLAIR signal in white matter, corpus callosum; microhemorrhages
• CT Brain: Diffuse cerebral edema (less sensitive than MRI)
• Fundoscopy: May show papilledema or retinal hemorrhages
• CBC/RFT/LFT/Electrolytes: To exclude metabolic causes

❓ Question

A 29-year-old healthy man develops severe headache, wide-based gait, drowsiness, and disorientation after rapidly ascending to 4,200 meters. SpO₂ is 68% on room air. What is the MOST APPROPRIATE immediate management?

✅ Correct Answer: C

Immediate descent is the definitive and life-saving treatment for High Altitude Cerebral Edema (HACE). Even a descent of 300–1000 m can be dramatically effective. This must be combined with:

• 💨 Supplemental oxygen (2–4 L/min via nasal cannula or mask) to correct severe hypoxemia
• 💊 Dexamethasone 8 mg loading dose IM/IV, then 4 mg every 6 hours — reduces cerebral edema
• 🏕️ Portable hyperbaric chamber (Gamow bag) — if descent is impossible or delayed

HACE is a medical emergency. Delay in descent is fatal.

❌ Why Not the Others?

• A – IV Mannitol only: While mannitol reduces ICP, it is not first-line for HACE and does not address altitude hypoxia. Descent is priority.
• B – Oral acetazolamide + observe: Acetazolamide is for AMS prophylaxis and mild AMS. HACE with altered consciousness, ataxia, and SpO₂ 68% requires immediate descent — observation is dangerous.
• D – CT head + await neurosurgery: At altitude with no CT available, this delays life-saving intervention. HACE is a clinical diagnosis; descent must not wait for imaging.

🟢 Physical Examination Pearls

• Tandem Gait Test: Walking heel-to-toe in a straight line; inability = cerebellar ataxia — hallmark of HACE
• HACE Triad: Severe headache + ataxia + altered consciousness at altitude = HACE until proven otherwise
• Fundoscopy: Retinal hemorrhages and papilledema support raised ICP
• AVPU Scale: Alert → Voice → Pain → Unresponsive; HACE patients may rapidly progress
• SpO₂ at Altitude: Expected drop at 4,200 m is to ~80–85%; SpO₂ <75% with symptoms = emergency
• Differentiate from HAPE: HAPE presents with cough, frothy sputum, crackles — both may coexist

🟡 Investigations — Choosing Wisely

• ✅ Do: Pulse oximetry is rapid, non-invasive, and essential for triage at altitude
• ✅ Do: MRI brain if evacuation complete — superior to CT for white matter edema, microhemorrhages
• ✅ Do: ABG to assess degree of hypoxia and acid-base status post-descent
• ❌ Don't: Delay descent to obtain CT scan — HACE is a clinical emergency
• ❌ Don't: Order lumbar puncture routinely — may herniate in raised ICP; only after imaging clears
• ⚠️ Note: EEG not routinely needed unless seizure suspected

🟣 Management

1

DESCEND IMMEDIATELY — minimum 300–1000 m; further if possible. This is the single most important intervention.

2

Supplemental Oxygen: 2–4 L/min via face mask; titrate to SpO₂ ≥90%

3

Dexamethasone: 8 mg IM/IV/PO loading dose → 4 mg every 6 hours (reduces vasogenic edema)

4

Gamow Bag: Portable hyperbaric chamber (2 psi above ambient) — buys time if descent impossible; simulates descent of ~1500 m

5

Avoid re-ascent until fully asymptomatic for ≥24 hours

6

Acetazolamide 250 mg BD — adjunct for acclimatization; not primary treatment for established HACE

7

Hospitalize post-descent for monitoring, neurological evaluation, MRI if indicated

🔵 Differential Diagnosis

Condition	Key Features	Differentiator from HACE
HACE	Ataxia, AMS, headache, SpO₂ ↓, at altitude	— Reference diagnosis —
HAPE	Dyspnea, cough, frothy sputum, crackles	Pulmonary not neurological; may coexist
Acute Mountain Sickness (AMS)	Headache, nausea, fatigue — no ataxia/AMS	No altered sensorium or gait disturbance
Hypoglycemia	Confusion, diaphoresis, rapid correction	Blood glucose low; responds to dextrose
Stroke / Intracranial bleed	Focal deficits, sudden onset	No altitude exposure; CT/MRI differentiates
Meningitis / Encephalitis	Fever, meningism, CSF changes	Fever prominent; not altitude-related
Carbon monoxide poisoning	Headache, confusion in tents/shelters	SpO₂ falsely normal; COHb elevated

🔴 Clinical Pitfalls

• ⚠️ Delaying descent to wait for clinical improvement — fatal error; descend first, treat en route
• ⚠️ Mistaking HACE for exhaustion or dehydration — ataxia + altered consciousness at altitude = HACE
• ⚠️ CO poisoning masked by altitude: Pulse oximetry reads falsely normal in CO poisoning (shared absorbance)
• ⚠️ Using acetazolamide alone for established HACE — it is prophylactic/mild AMS adjunct only
• ⚠️ Overlooking HAPE co-occurrence: 14% of HACE cases have concurrent HAPE — assess lung fields
• ⚠️ Re-ascent too early: Neurological sequelae risk if re-ascent within 24 hours of symptom resolution
• ⚠️ LP without imaging in suspected raised ICP can cause cerebral herniation

💬 Open-Type FAQ (10 Questions)

Q1. What altitude is considered high enough to cause HACE?

HACE typically occurs above 3,000–4,000 m, particularly with rapid ascent without adequate acclimatization. Risk increases with higher altitudes and faster rates of ascent.

Q2. How is HACE distinguished from AMS?

AMS causes headache, nausea, and fatigue without neurological deficits. HACE is AMS that has progressed to include ataxia and/or altered consciousness — it is a medical emergency.

Q3. What is the pathophysiology of HACE?

Hypoxia induces vasodilation and increased cerebral blood flow. VEGF-mediated breakdown of the blood-brain barrier leads to vasogenic edema, cytotoxic edema, and raised intracranial pressure.

Q4. Can HACE occur in healthy, fit individuals?

Yes. Physical fitness does not protect against altitude illness. HACE depends on rate of ascent, altitude, and individual genetic susceptibility — not aerobic fitness.

Q5. What is the role of dexamethasone in HACE?

Dexamethasone reduces vasogenic cerebral edema by decreasing vascular permeability and VEGF activity. It is adjunctive — descent remains the primary treatment.

Q6. What is the Gamow Bag and when is it used?

A Gamow Bag is a portable hyperbaric chamber that increases ambient pressure to simulate descent of ~1,500 m. It is used when immediate physical descent is impossible, as a temporary bridge.

Q7. What is the recommended rate of ascent to prevent HACE?

Above 3,000 m, the "climb high, sleep low" rule applies. Sleeping altitude should not increase by more than 300–500 m/day, with a rest day every 3rd day of ascent.

Q8. Can HACE recur on future altitude exposure?

Yes. Previous HACE is a significant risk factor for recurrence. Survivors should ascend more slowly, use acetazolamide prophylaxis, and have a low threshold for descent on future trips.

Q9. What are the long-term neurological sequelae of HACE?

Most patients recover fully if treated promptly. Delayed treatment may result in persistent cerebellar ataxia, cognitive impairment, or white matter changes on MRI. Death can occur in untreated cases.

Q10. What prophylactic medications are recommended for high-altitude ascent?

Acetazolamide 125–250 mg BD starting 1–2 days before ascent is first-line prophylaxis. Dexamethasone can be used if acetazolamide is contraindicated (sulfa allergy).

📚 Key Guidelines & References

• 🔵 Wilderness Medical Society (WMS) 2019 Guidelines — Practice guidelines for the prevention and treatment of acute altitude illness
• 🔵 Lake Louise AMS Score (LLS) — Validated scoring for AMS; HACE = LLS + ataxia or altered consciousness
• 🔵 Hackett PH, Roach RC. High-altitude illness. N Engl J Med. 2001;345(2):107-114
• 🔵 Gallagher SA, Hackett PH. High altitude illness. UpToDate 2024 (current edition)
• 🔵 WHO Mountain Medicine Handbook — Travel at altitude: reducing the risk
• 🔵 UIAA MedCom Recommendations — Medical guidelines for mountaineering expeditions

🔍 SEO Keywords

#HACE #HighAltitudeCerebralEdema #AltitudeIllness #FCPSMedicine #InternalMedicineQuiz #MCQPrep #MRCPPart1 #AcuteMountainSickness #CerebralEdema #EmergencyMedicine

© Internal Medicine Quiz · internalmedicinequiz.blogspot.com · For MCPS, FCPS, MRCP Exam Candidates

📚 Internal Medicine Quiz

Follow our Facebook page for more Internal Medicine MCQs, Clinical Cases, FCPS Preparation & Exam Pearls.

🔗 Visit Internal Medicine Quiz Facebook Page

🔗 Explore More Topics:

🫀 Cardiology 🫁 Respiratory 🧠 Neurology 🩸 Hematology 🧪 Nephrology 🦠 Gastroenterology 🏥 Hepatology 🦴 Rheumatology 💉 Endocrinology 🩺 ABG 🧩 Psychiatry ☠️ Poisoning 🌿 Environment

🏠 Back to Home  |  📬 Contact Us  |  📋 About Us